Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BEVACIZUMAB-BVZR Cause Incorrect dose administered? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Incorrect dose administered have been filed in association with BEVACIZUMAB-BVZR. This represents 1.2% of all adverse event reports for BEVACIZUMAB-BVZR.

7
Reports of Incorrect dose administered with BEVACIZUMAB-BVZR
1.2%
of all BEVACIZUMAB-BVZR reports
2
Deaths
3
Hospitalizations

How Dangerous Is Incorrect dose administered From BEVACIZUMAB-BVZR?

Of the 7 reports, 2 (28.6%) resulted in death, 3 (42.9%) required hospitalization.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-BVZR. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does BEVACIZUMAB-BVZR Cause?

Off label use (159) Death (149) Neoplasm progression (80) Fatigue (57) Hypertension (41) Blood pressure increased (39) Weight decreased (39) Weight increased (34) Inappropriate schedule of product administration (28) Malaise (28)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which BEVACIZUMAB-BVZR Alternatives Have Lower Incorrect dose administered Risk?

BEVACIZUMAB-BVZR vs BEVACIZUMAB-MALY BEVACIZUMAB-BVZR vs BEXAROTENE BEVACIZUMAB-BVZR vs BEZAFIBRATE BEVACIZUMAB-BVZR vs BEZLOTOXUMAB BEVACIZUMAB-BVZR vs BGB-11417

Related Pages

BEVACIZUMAB-BVZR Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered BEVACIZUMAB-BVZR Demographics